These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 13185038)

  • 1. [Multiple unsaturated fatty acids (secretal) in the therapy of chronic parenchymal diseases of the liver].
    SCHULZ GS
    Medizinische; 1954 Jul; 29-30():1007-9. PubMed ID: 13185038
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dietetic therapy of liver diseases].
    Knick B; Ottenjann R; Gruner J; Kanzler G
    Minerva Med; 1972 Jun; 63(49):2756-8. PubMed ID: 5040417
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of liver parenchymal diseases with total liver extracts].
    LASCH F
    Gastroenterologia; 1954 Nov; 82(5):270-84. PubMed ID: 13232153
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experience with solcohepsyl in the treatment of chronic liver diseases].
    Güemes Diaz F
    Rev Esp Enferm Apar Dig; 1965; 24(6):761-72. PubMed ID: 5891987
    [No Abstract]   [Full Text] [Related]  

  • 5. [The therapy of chronic hepatitis and liver cirrhoses with liver-mitochondrial suspensions].
    HOETZL HA
    Munch Med Wochenschr; 1960 Sep; 102():1670-4. PubMed ID: 13714958
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of chronic liver diseases].
    Geisenhainer G
    Z Arztl Fortbild (Jena); 1972 Dec; 66(23):1199-201. PubMed ID: 4652157
    [No Abstract]   [Full Text] [Related]  

  • 7. [The treatment of chronic liver diseases with liver hydrolysates].
    GORGES T; FRANZEN F
    Munch Med Wochenschr; 1954 May; 96(21):614-7. PubMed ID: 13176395
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the level of highly unsaturated fatty acids in the blood serum of patients with chronic hepatitis and cirrhosis of the liver].
    Velikov VK
    Ter Arkh; 1966 Jan; 38(1):47-50. PubMed ID: 5982213
    [No Abstract]   [Full Text] [Related]  

  • 9. [Individual therapy of inflammatory liver diseases (conditions, difficulties, results)].
    Brühl W
    Z Allgemeinmed; 1969 Apr; 45(12):562-7. PubMed ID: 5785117
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experience in treating chronic hepatitis and liver cirrhosis in children].
    Deputatova LD; Men'kova TN; Lyskova TF; Chikalova AV
    Vopr Okhr Materin Det; 1978 Mar; 23(3):35-9. PubMed ID: 644947
    [No Abstract]   [Full Text] [Related]  

  • 11. [The current status of treatment of chronic hepatitis, liver cirrhosis and of their complications].
    NEIGER A
    Ther Umsch; 1961 Jan; 18():4-11. PubMed ID: 13728202
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical experience in the treatment of acute and chronic hepatitis as well as of compensated and decompensated liver cirrhosis with the liver hydrolysate prohepar].
    RASBACH K
    Med Monatsschr; 1955 Apr; 9(4):232-6. PubMed ID: 14393497
    [No Abstract]   [Full Text] [Related]  

  • 13. [The place of cortisone drugs in the treatment of chronic hepatitis and of liver cirrhosis].
    DIMITRIU CC; BULIGESCU L
    Med Interna (Bucur); 1961 May; 13():689-701. PubMed ID: 13722921
    [No Abstract]   [Full Text] [Related]  

  • 14. [Extents of daily activities allowed in chronic hepatitis and liver cirrhosis].
    Murai K; Tsuji H; Kawadoko T; Fujishima M
    Fukuoka Igaku Zasshi; 1989 Aug; 80(8):422-4. PubMed ID: 2583654
    [No Abstract]   [Full Text] [Related]  

  • 15. [Triamcinolone in therapy of some liver diseases].
    GARAGNANI A; CAVASSINI GB
    Arch Ital Mal Appar Dig; 1959; 25(4):251-76. PubMed ID: 13618136
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical studies on the therapeutic effect of the liver hydrolysate prohepar in the therapy of liver diseases under control of functional disorders in protein and bile pigment metabolism].
    GOHR H; GORGES T
    Z Gesamte Inn Med; 1953 Dec; 8(23):1073-7. PubMed ID: 13170184
    [No Abstract]   [Full Text] [Related]  

  • 17. [Possibilities of immunotherapy in chronic liver diseases].
    Kurdybaĭlo FV; Iakhontova OI; Efanov AN
    Klin Med (Mosk); 1982 Sep; 60(9):49-53. PubMed ID: 7176488
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effectiveness of health resort treatment of chronic hepatitis and liver cirrhosis with lipotropic factors as diet supplement].
    NOGALLER AM
    Sov Med; 1958 Oct; 22(10):65-74. PubMed ID: 13615523
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of magnesium electrophoresis in complex treatment of chronic liver diseases in children].
    Anan'eva KA; Savel'eva LA; Nikolaeva VV; Dedikova LA
    Vopr Okhr Materin Det; 1975 Mar; 20(3):14-5. PubMed ID: 1121766
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical and biochemical observations on the use of large doses of testosterone propionate in acute and chronic liver disease.
    MORGAN FM; WHARTON GK; STARR P; COMMONS RR
    Am J Gastroenterol; 1954 Feb; 21(2):89-120. PubMed ID: 13124314
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.